1Munro IC,Ford RA,Kennepohl E,et al.Correlation of structral class with no observed effect levels:a proposal for establishing a threshold of concern[J].Food and Chemical Toxicology,1996,34:829-867.
2Munro IC,Kennepoh1 E,Kroes R.A precedure for the safety evaluation of flavouring substances[J].Food and Chemical Toxicology,1999,37:207-232.
3Renwick AG.Toxicology databases and the concept of thresholds of toxicological concern as used by the JFCFA for the safety evaluation of flavoring agents[J].Toxicology Letters,2004,149:223 -234.
4Barlow SM,Kozianowski G,Wurtzen G,et al.Threshold of toxicological concern for chemical shubstsnces present in the diet[J].Food and Chemical Toxicology,2001,39:893-905.
5Cheeseman MA,Machuga EJ,Bailey AB.A tiered approach to threshold of regulaion[J].Food and Chemical Toxicology,1999,37:387-418.
6Gold LS,Manley NB,Slone TH,et al.Supplement to the carcinogenic potency databaese(CPDB):results of animal bioassays published in the general literature in 1993 to 1994 and by the National Toxicology program in 1995 to 1996[J].Enviroment Health Perspective,1999,107(suppl1.4):3-123.
7US EPA.Guideline for neurotoxicity risk assessment[OE].US Environmental Protection Agency.1998.Http://www.epa.gov.ncea.
8Chen WL,Sheets J J,Nolan RJ,et al.Human red blood cell acetylcholinesterase inhbition as the appropriate and concervative surrogate endpoint for establishing chlorpyriphos reference does[J].Regulatory Toxiology,1999,29:15-22.
9Munro IC,Kennepohl E.Comparison of estimated daily per capita intakes of flavouring substances with no-observed effect levels from animal studiess[J].Food and Chemical Toxicology,201,39:331-354.
10Taylor SL,Hefle SL,Bindslev-Jensen C,et al.Factors affecting the determination of threshold doses for allergenic foods:how much is too much?[J].Journal of Allergy and Clinical Immunology,2002,109:24-30.
7Dennis J. Compatibility of Pharmaceutical Products and Contactmaterials [M]. New Jersey: John Wiley & Sons, Inc., 2008.
8Ball D J, Norwood DL, Stults CLM, et al. Leachables and Extractables Handbook: Safety Evaluation, Qualification, and Best Practices Applied to Inhalation Drug Products [M]. New Jersey: John Wiley & Sons, Inc., 2008.
9ICH: Impurities in New Drug Substances, Q3A (R). 2006 [EB/OL]. http://www.ich.org/fileadmin/Public Web Site/ ICH Products/Guidelines/Quality/Q3A R2/Step4/Q3A R2 Guideline.pdf.
10ICH: Impurities in New Drug Products, Q3B (R). 2006[EB/OL]. http://www.ich.org/fileadmin/Public Web Site/ ICH Produets/Guidelines/Quality/Q3B R2/Step4/Q3B R2 Guideline.pdf.
